TrialIndian journal of pharmacology2026

Efficacy and safety of different doses of apremilast in mild to-moderate psoriasis: A randomized controlled study.

Abhishek Anil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.